These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11738359)

  • 1. Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice.
    Leriche-Guérin K; Anderson LV; Wrogemann K; Roy B; Goulet M; Tremblay JP
    Neuromuscul Disord; 2002 Feb; 12(2):167-73. PubMed ID: 11738359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning of the mouse dysferlin gene and genomic characterization of the SJL-Dysf mutation.
    Vafiadaki E; Reis A; Keers S; Harrison R; Anderson LV; Raffelsberger T; Ivanova S; Hoger H; Bittner RE; Bushby K; Bashir R
    Neuroreport; 2001 Mar; 12(3):625-9. PubMed ID: 11234777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective membrane repair in dysferlin-deficient muscular dystrophy.
    Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
    Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.
    Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y
    FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.
    Millay DP; Maillet M; Roche JA; Sargent MA; McNally EM; Bloch RJ; Molkentin JD
    Am J Pathol; 2009 Nov; 175(5):1817-23. PubMed ID: 19834057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy.
    Liu J; Aoki M; Illa I; Wu C; Fardeau M; Angelini C; Serrano C; Urtizberea JA; Hentati F; Hamida MB; Bohlega S; Culper EJ; Amato AA; Bossie K; Oeltjen J; Bejaoui K; McKenna-Yasek D; Hosler BA; Schurr E; Arahata K; de Jong PJ; Brown RH
    Nat Genet; 1998 Sep; 20(1):31-6. PubMed ID: 9731526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).
    Weiler T; Bashir R; Anderson LV; Davison K; Moss JA; Britton S; Nylen E; Keers S; Vafiadaki E; Greenberg CR; Bushby CR; Wrogemann K
    Hum Mol Genet; 1999 May; 8(5):871-7. PubMed ID: 10196377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of MHC class I expression accompanies but is not required for spontaneous myopathy in dysferlin-deficient SJL/J mice.
    Kostek CA; Dominov JA; Miller JB
    Am J Pathol; 2002 Mar; 160(3):833-9. PubMed ID: 11891182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.
    Tagawa K; Ogawa M; Kawabe K; Yamanaka G; Matsumura T; Goto K; Nonaka I; Nishino I; Hayashi YK
    J Neurol Sci; 2003 Jul; 211(1-2):23-8. PubMed ID: 12767493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL).
    Suzuki N; Aoki M; Hinuma Y; Takahashi T; Onodera Y; Ishigaki A; Kato M; Warita H; Tateyama M; Itoyama Y
    Neurosci Res; 2005 May; 52(1):47-60. PubMed ID: 15811552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of the dysferlin skeletal muscle promoter.
    Foxton RM; Laval SH; Bushby KM
    Eur J Hum Genet; 2004 Feb; 12(2):127-31. PubMed ID: 14560310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B.
    Nagaraju K; Rawat R; Veszelovszky E; Thapliyal R; Kesari A; Sparks S; Raben N; Plotz P; Hoffman EP
    Am J Pathol; 2008 Mar; 172(3):774-85. PubMed ID: 18276788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies).
    Anderson LV; Harrison RM; Pogue R; Vafiadaki E; Pollitt C; Davison K; Moss JA; Keers S; Pyle A; Shaw PJ; Mahjneh I; Argov Z; Greenberg CR; Wrogemann K; Bertorini T; Goebel HH; Beckmann JS; Bashir R; Bushby KM
    Neuromuscul Disord; 2000 Dec; 10(8):553-9. PubMed ID: 11053681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
    Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
    Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.
    Wenzel K; Carl M; Perrot A; Zabojszcza J; Assadi M; Ebeling M; Geier C; Robinson PN; Kress W; Osterziel KJ; Spuler S
    Hum Mutat; 2006 Jun; 27(6):599-600. PubMed ID: 16705711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel, blood-based diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy.
    Ho M; Gallardo E; McKenna-Yasek D; De Luna N; Illa I; Brown RH
    Ann Neurol; 2002 Jan; 51(1):129-33. PubMed ID: 11782994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/dy) mouse muscles.
    Vilquin JT; Guérette B; Puymirat J; Yaffe D; Tomé FM; Fardeau M; Fiszman M; Schwartz K; Tremblay JP
    Gene Ther; 1999 May; 6(5):792-800. PubMed ID: 10505103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy.
    Illarioshkin SN; Ivanova-Smolenskaya IA; Greenberg CR; Nylen E; Sukhorukov VS; Poleshchuk VV; Markova ED; Wrogemann K
    Neurology; 2000 Dec; 55(12):1931-3. PubMed ID: 11134403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoblast transplantation in non-dystrophic dog.
    Ito H; Vilquin JT; Skuk D; Roy B; Goulet M; Lille S; Dugré FJ; Asselin I; Roy R; Fardeau M; Tremblay JP
    Neuromuscul Disord; 1998 Apr; 8(2):95-110. PubMed ID: 9608563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myoferlin, a candidate gene and potential modifier of muscular dystrophy.
    Davis DB; Delmonte AJ; Ly CT; McNally EM
    Hum Mol Genet; 2000 Jan; 9(2):217-26. PubMed ID: 10607832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.